Citigroup’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Citigroup’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-549	Closed	-$19.7K	–	6088
2022 Q4	$19.7K	Sell	549 -604	-52%	-$15.1K	﹤0.01%	4603
2022 Q3	$17K	Sell	1,153 -1,467	-56%	-$23.8K	﹤0.01%	4810
2022 Q2	$35K	Buy	2,620 +748	+40%	+$11.9K	﹤0.01%	4707
2022 Q1	$36K	Sell	1,872 -1,794	-49%	-$37.2K	﹤0.01%	4884
2021 Q4	$87K	Buy	3,666 +2,159	+143%	+$50K	﹤0.01%	4805
2021 Q3	$30K	Buy	+1,507	New	+$32.3K	﹤0.01%	5041

Citigroup's IMGO Position: Q1 2023 in Review

Citigroup sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 549 shares — an estimated $19.7K sold.

Citigroup first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $87K in Q4 2021. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Citigroup reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Citigroup sold 549 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $19.7K.
Citigroup first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
Citigroup's Imago BioSciences, Inc. Common stock position peaked at $87K in Q4 2021.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.